Download Files:
Broxaldine
SKU
HY-B1143-10 mg
Category Reference compound
Tags Anti-infection, Bacterial;Fungal;Parasite, Infection
$38 – $66
Products Details
Product Description
– Broxaldine (Brobenzoxaldine) is an antiprotozoal agent. Broxaldine inhibits Clostridium difficile with a MIC value of 4 µM, and has antifungal effects[1][2].
Web ID
– HY-B1143
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C17H11Br2NO2
References
– [1]Hazra SK, et al. Therapeutic trial of a combination of broxyquinoline and brobenzoxaldine in the treatment of leprosy. Lepr India. 1979 Oct;51(4):505-10.|[2]AbdelKhalek A, et al. Screening for potent and selective anticlostridial leads among FDA-approved drugs. J Antibiot (Tokyo). 2020 Mar 4.
CAS Number
– 3684-46-6
Molecular Weight
– 421.08
Compound Purity
– 99.50
SMILES
– CC1=NC2=C(OC(C3=CC=CC=C3)=O)C(Br)=CC(Br)=C2C=C1
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– DMSO : 8.33 mg/mL (ultrasonic)
Target
– Bacterial;Fungal;Parasite
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.